Comparison
Omega-3 (DHA/EPA) vs Mexidol (Emoxypine)
Omega-3 (DHA/EPA)
Essential fatty acids critical for brain structure and function. DHA comprises ~40% of brain polyunsaturated fatty acids.
Mexidol (Emoxypine)
Russian prescription antioxidant and anti-anxiety compound. Membrane stabiliser used for cerebrovascular and anxiety conditions.
| Field | Omega-3 (DHA/EPA) | Mexidol (Emoxypine) |
|---|---|---|
| Category | neuroprotective | neuroprotective |
| Dose range | 1000–3000mg | 125–500mg |
| Half-life | 24h | — |
| Onset | — | — |
| Evidence | EVIDENCEA | EVIDENCEC |
| Safety | ●●●●● | ●●●●○ |
| Legal (US) | USOTC | USResearch chemical |
| PubMed refs | 5200 | 200 |
The comparison in plain English
Auto-generated from dataOmega-3 (DHA/EPA) and Mexidol (Emoxypine) are both in the neuroprotective category respectively. Omega-3 (DHA/EPA) Essential fatty acids critical for brain structure and function. Mexidol (Emoxypine) Russian prescription antioxidant and anti-anxiety compound.
Bottom line
Omega-3 (DHA/EPA) (evidence A, safety 5/5) has a weaker evidence base than Mexidol (Emoxypine) (evidence C, safety 4/5). Omega-3 (DHA/EPA) has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Omega-3 (DHA/EPA) if
Omega-3 (DHA/EPA) is the better fit when your goal aligns with its mechanism (DHA (docosahexaenoic acid) is a structural component of neuronal cell membranes, maintaining fluidity and supporting receptor function) and the dose range (1000–3000mg) suits your protocol. Half-life is 24h.
Choose Mexidol (Emoxypine) if
Mexidol (Emoxypine) is the better fit when your goal aligns with its mechanism (Antioxidant through scavenging reactive oxygen species and stabilising membrane lipid bilayer) and the dose range (125–500mg) suits your protocol. Half-life is —h.